Document is current
Any future updates will be listed below
-
Authors
O’Driscoll, Jessica
Burton, Anya
Maskarinec, Gertraud
Perez-Gomez, Beatriz
Vachon, Celine
Miao, Hui
Lajous, Martín
López-Ridaura, Ruy
Eliassen, A. Heather
Pereira, Ana
Garmendia, Maria Luisa
Tamimi, Rulla M.
Bertrand, Kimberly
Kwong, Ava
Ursin, Giske
Lee, Eunjung
Qureshi, Samera A.
Ma, Huiyan
Vinnicombe, Sarah
Moss, Sue
Allen, Steve
Ndumia, Rose
Vinayak, Sudhir
Teo, Soo-Hwang
Mariapun, Shivaani
Fadzli, Farhana
Peplonska, Beata
Nagata, Chisato
Stone, Jennifer
Hopper, John L.
Giles, Graham
Ozmen, Vahit
Aribal, Mustafa Erkin
Schüz, Joachim
Van Gils, Carla H.
Wanders, Johanna O. P.
Sirous, Reza
Sirous, Mehri
Hipwell, John
Kim, Jisun
Lee, Jong Won
Hartman, Mikael
Li, Jingmei
Scott, Christopher
Chiarelli, Anna M.
Linton, Linda
Pollan, Marina
Flugelman, Anath Arzee
Salem, Dorria
Kamal, Rasha
Boyd, Norman
dos-Santos-Silva, Isabel
McCormack, Valerie
Mullooly, Maeve
-
Funding
Funding for this research was provided by:
Health Research Board (EIA-2019-012, EIA-2019-012)
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 5 September 2024
First Online: 30 September 2024
Declarations
:
: Ethics approvals for the ICMD were obtained from the International Agency for Research on Cancer (IEC 12 ± 34). Each individual participating study had received local ethical approval at the time of the original conduct of the study and again to contribute to the consortium.
: Not applicable.
: ML has received a non-restricted investigator-initiated grant from AstraZeneca and minor support from Swiss Re. All other co-authors declare that they have no competing interests.
